Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP334484.RACCmh2K-4GakDaNTedA6wqxVLnE9tlKQlLjr-HLzWARU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP334484.RACCmh2K-4GakDaNTedA6wqxVLnE9tlKQlLjr-HLzWARU130_assertion type Assertion NP334484.RACCmh2K-4GakDaNTedA6wqxVLnE9tlKQlLjr-HLzWARU130_head.
- NP334484.RACCmh2K-4GakDaNTedA6wqxVLnE9tlKQlLjr-HLzWARU130_assertion description "[Mutational analysis showed 10 (40%) of 25 uterine endometrioid carcinomas; none of 12 uterine serous carcinomas and none of 56 ovarian serous and mucinous carcinomas harbored somatic ARID1A mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP334484.RACCmh2K-4GakDaNTedA6wqxVLnE9tlKQlLjr-HLzWARU130_provenance.
- NP334484.RACCmh2K-4GakDaNTedA6wqxVLnE9tlKQlLjr-HLzWARU130_assertion evidence source_evidence_literature NP334484.RACCmh2K-4GakDaNTedA6wqxVLnE9tlKQlLjr-HLzWARU130_provenance.
- NP334484.RACCmh2K-4GakDaNTedA6wqxVLnE9tlKQlLjr-HLzWARU130_assertion SIO_000772 21412130 NP334484.RACCmh2K-4GakDaNTedA6wqxVLnE9tlKQlLjr-HLzWARU130_provenance.
- NP334484.RACCmh2K-4GakDaNTedA6wqxVLnE9tlKQlLjr-HLzWARU130_assertion wasDerivedFrom befree-20140225 NP334484.RACCmh2K-4GakDaNTedA6wqxVLnE9tlKQlLjr-HLzWARU130_provenance.
- NP334484.RACCmh2K-4GakDaNTedA6wqxVLnE9tlKQlLjr-HLzWARU130_assertion wasGeneratedBy ECO_0000203 NP334484.RACCmh2K-4GakDaNTedA6wqxVLnE9tlKQlLjr-HLzWARU130_provenance.